|
|
|
|
|
|
Sponsored by: |
University of Zurich |
Information provided by: | University of Zurich |
ClinicalTrials.gov Identifier: | NCT00658294 |
The aim of this study is to evaluate PET-CT and EmII/3-10 serology as potential markers to assess the parasitocidal effect of benzimidazoles
Condition | Intervention | Phase |
Alveolar Echinococcosis |
Other: Stop treatment |
Phase IV |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles in Patients With Inoperable Alveolar Echinococcosis Using PET-CT and EmII/3-10 Serology |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Patients with inoperable alveolar echinococchosis
Inclusion criteria:
Exclusion criteria:
Contact: 01 Studienregister MasterAdmins | 41-044-255-1111 |
Switzerland | |||||
University Hospital Zurich | Recruiting | ||||
Zurich, Switzerland | |||||
Contact Beat.Müllhaupt@usz.ch | |||||
Contact Beat.Müllhaupt@usz.ch |
University of Zurich |
Principal Investigator: | Beat Müllhaupt 01 Studienregister MasterAdmins | UniversitaetsSpital Zuerich |
Responsible Party: | University Hospital Zurich ( Beat Müllhaupt ) |
Study ID Numbers: | EK-1351 |
First Received: | April 8, 2008 |
Last Updated: | April 11, 2008 |
ClinicalTrials.gov Identifier: | NCT00658294 |
Health Authority: | Switzerland: Swissmedic |
|
|
|
|